Symposia: Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, clinical trials, adult, Translational Research, Thalassemia, Combination therapy, Clinical Research, Hemoglobinopathies, GVHD, pediatric, Diseases, Immune Disorders, Therapies, real-world evidence, Lymphoid Malignancies, registries, young adult , Myeloid Malignancies, Study Population, Human, Transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, clinical trials, adult, Translational Research, Thalassemia, Combination therapy, Clinical Research, Hemoglobinopathies, GVHD, pediatric, Diseases, Immune Disorders, Therapies, real-world evidence, Lymphoid Malignancies, registries, young adult , Myeloid Malignancies, Study Population, Human, Transplantation
Sunday, December 11, 2022: 12:00 PM-1:30 PM
208-210
(Ernest N. Morial Convention Center)
Moderators:
Muna Qayed, MD, MSc, ARRAY(0xf7283e0)
and
Divya Koura, MD, UCSD Moores Cancer Center
Disclosures:
Qayed: Novartis: Honoraria; Vertex: Honoraria. Koura: Cidara: Consultancy.
This session will focus on large studies of the treatment of GVHD, including large real-world observations and randomized studies.
12:00 PM
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH